Fig. 2 | Bone Marrow Transplantation

Fig. 2

From: Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusions

Fig. 2

The mean fluorescence intensity (MFI) of the HLA-A2 antibody is depicted in black diamonds. White blood cell count is shown as open triangles. The time points of HLA-A2-positive apheresis platelet transfusion (A2-PT) are indicated as well as the application of rituximab (R) and bortezomib (B). FBM = non-myeloablative conditioning with fludarabine, carmustine, melphalan and antithymocyte globulin; HCT = hematopoietic cell transplantation on day zero

Back to article page